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Abstract 
Ardhavabhedaka defines Ardha Mastak Vedana. The word migraine is derived from the Greek word hemi-
cranias, meaning "half of the head". Migraine is now recognized as a chronic illness, not simply a headache. Many 
medications have been tried and a lot are still in research work also, but modern drugs are not acceptable due to 
their drawbacks. In contrast to that Ayurveda has a variety of natural medication in the treatment of Ardhavabheda-
ka. It was planned to compare the result between Laghu Sutashekhara Rasa orally in Group A, Brihat Dashamoola 
Taila Nasya in Group B, placebo drug in Group C and Go-ghrita Nasya in Group D. The overall effect of therapy 
showed that in Group A 38% patients cured and 36% patients got marked improvement. In Group B 46.67% pa-
tients moderately improved and 35.55% patients marked improved. In Group C 90% patients unchanged. In Group 
D 48.89% patients moderately improved and 28.89% patients marked improved. No any adverse drug reaction was 
found during whole study. Total 150 patients were registered and from the results and observation which were re-
ceived from this study it can be concluded that Group A is showing better results in Ardhavabhedaka. 
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Introduction: 
Headache has troubled mankind from dawn of 
civilization. Neurovascular headaches are the second 
most common primary headaches, which includes 
migraine(1). The term "migraine" refers to a syndrome 
of vascular spasms of the cranial blood vessels. 
Migraine is now recognized as a chronic illness, not 
simply a headache(2). Many medications have been 
tried and a lot are still in research work also, but 
modern drugs are not acceptable due to their 
drawbacks. All the medications, either the older one or 
the newly available one have a lot of side effects (GIT 
distress, etc). In contrast to that Ayurveda has a 
variety of natural medication in the treatment of 
various types of Shiro-Roga. Thus, here an attempt 
has been made to evaluate the efficacy of Shamana 
Yoga – Laghu Sutashekhara Rasa from Rasa 
Tarangini(3), which is having digestive, anti-oxidant, 
anti-inflammatory properties and Vata-Kaphahara 
quality of Gairika, Shunthi and Betel leaves. As a 
Shodhana therapy Brihat Dashamoola Taila from 
Bhaisajya Ratnavali(4), which is having Vatahara 
properties, has been selected in the present study. 
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According to Acharya Sushruta(5), Ardhavabhedaka is 
best treated with Ghrita and it is effective in subsiding 
Pittaja and Vataja disorders; it improves Dhatus and is 
overall booster for improving Ojas. 
So here the clinical study has been planned to find 
out the efficacy of Brihat Dashamoola Taila and Go-
ghrita as Nasya and Laghu Sutashekhara Rasa as oral 
drug in comparison of placebo drug for the treatment of 
Ardhavabhedaka 
 
Aims and objectives: 
The present study was based on following aims 
and objects: 
To study the etiopathogenesis of Ardhavbhedaka 
- Migraine from Ayurvedic and modern point of view. 
To evaluate the efficacy of Laghu Sutashekhara 
Rasa (orally) and Brihata Dashamoola Taila (Nasya) in 
patients suffering from Ardhavabhedaka – Migraine.   
 
Materials and methods: 
For clinical study, patients attending O.P.D. & 
I.P.D. of Department of Shalakya, I.P.G.T. & R.A., 
hospital fulfilling the criteria for diagnosis were selected 
randomly, irrespective of their Desha, Jati, Prakriti, 
Sattva etc. Patients’ written informed consent was taken 
before starting the treatment. The study was conducted 
in 150 subjects. CTRI reg. no. is 2015/07/009321. The 
study was approved by Institutional Ethics Committee 
(No.PGT/7/A/Ethics/2011-12/2687 dated on 
23/08/2011). 
 
Diagnostic criteria:  
Criteria for inclusion: Age Control group between 16 
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to 60 years and having sign and symptom of 
Ardhavabhedaka (Migraine) according to Ayurvedic 
Classics as well as Modern science. The diagnosis of 
the disease shall be done on the basis of clinical 
manifestations like recurrent attacks of headache, 
mostly unilateral in site, variable in intensity, frequency 
and duration with or without nausea, vomiting, aura and 
GI tract symptoms. 
 
Criteria for exclusion:  
 Sinusitis, hypertension, fever, Secondary 
headache caused by meningitis, tumour, encephalitis, 
cervical spondylitis and refractive errors. Patients using 
any other systemic drugs which may alter the results of 
study. 
 
Grouping: 
Group A:  Laghu Sutashekhara Rasa: (Rasa  
  Tarangini Parishista) 
                 Dose - 500 mg Tablet thrice per day orally  
                 Duration - 02 Months.  
 
Group B:  Brihata Dashamoola Taila for Nasya    
  (Bhaishajya Ratnavali 65/94-98) 
                 Dose- 6 - 8 drops in each nostril. 
                 Duration- (02 Months) 4 sittings, each 
  sitting of 7 days at the interval of 1 week. 
 
Group C:  Placebo Tablet prepared by wheat floor. 
                 Dose - 500 mg Tablet thrice per day orally  
                 Duration - 02 Months.  
 
Group D:  Go-Ghrita Nasya: (Su. U. 26/31-35) 
                 Dose- 6- 8 drops in each nostril. 
                 Duration- (02 Months) 4 sittings, each 
  sitting of 7 days at the interval of 1 week. 
 
Investigations: 
Routine haematological, urine and blood sugar 
level analysis was carried out before treatment to rule 
out any disease. Digital PNS X-Ray, Ophthalmologic 
Fundus examination, Nasal endoscopy and CT-SCAN 
was done wherever required.  
 
Scoring pattern: 
Subjective symptoms  
The improvement in patients was assessed on 
the basis of relief in the signs and symptoms of the 
disease. The details of the score adopted for the main 
signs and symptoms in this study are as follows: 
 
Severity of Headache 
0 =  No headache. 
1 =  Mild headache, patient is aware only if he/she 
pay attention to it. 
2 =  Moderate headache, can ignore at times. 
3 =  Severe headache, can’t ignore but he/she can 
do his/her usual activities. 
4 =  Excruciating headache, can’t do anything. 
 
Frequency of Headache: Assessed in term of (frequency 
in days) 
0 =  Nil 
1 =  ≥ 20 days 
2 =  15 days 
3 =  10 days 
4 =  ≤ 5 days 
 
Duration of Headache: (Assessed in term of hours/day) 
0 =  Nil 
1 =  1-3 hours/day 
2 =  3-6 hours/day 
3 =  6-12 hours/day 
4 =  More than 12 hours/day 
 
Nausea: 
0 =  Nil 
1 =  Occasionally 
2 =  Moderate, but does not disturb the routine 
work 
3 =  Severe, disturbing routine work 
4 =  Severe enough, small amount of fluid 
regurgitating from Mouth 
 
Vomiting: 
0 =  Nil 
1 =  Only if headache does not subside 
2 =  Vomiting 1-2 times 
3 =  Vomiting 2-3 times 
4 =  Forced to take medicine to stop vomiting 
 
Vertigo: 
0 =  Nil 
1 =  Feeling of giddiness 
2 =  Patient feels as if everything is revolving 
3 =  Revolving signs + black outs 
4 =  Unconscious 
 
Aura: 
0 =  Nil 
1 =  Lasts for 5 minutes. 
2 =  Lasts for 15 minutes 
3 =  Lasts for 30 minutes 
4 =  Lasts for 60 minutes 
 
Gradation For Associated Symptoms: 
0 =  No symptoms 
1 =  Mild (can do his/her work) 
2 =  Moderate (forced to stop work) 
3 =  Severe (forced to take rest) 
4 =  Excruciating (force to take medicine) 
 
Overall assessment: 
 The improvement was assessed on the basis of 
subjective symptoms and salivary tests (objective 
parameters). 
 
Subjective:  
The assessment was done by adopting the 
following scoring pattern for subjective symptoms- 
 Complete Remission: 100% relief in objective 
and subjective signs and symptoms. 
 Marked improvement: 76 – 99% relief in 
objective and subjective signs and symptoms. 
 Moderate improvement: 51 – 75% relief in 
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objective and subjective signs and symptoms. 
 Mild improvement: 26 – 50% relief in objective 
and subjective signs and symptoms. 
 Unchanged: Below 25% relief in objective and 
subjective signs and symptoms. 
 
Statistical estimation of results: 
The obtained data were analyzed statistically. The 
values were expressed as percentage of relief and 
Standard Error Mean. The data were analyzed by paired 
‘t’ test. Unpaired ‘t’ test was applied for comparative 
study. 
 P > 0.05 = Insignificant 
 P < 0.05 and 0.01 = Significant 
 P < 0.001 = Highly significant 
 
Observations and Results 
In this clinical trial of Ardhavabhedaka, a total 
number of 150 patients were registered and were 
randomly distributed into four groups. The general 
observations are shown in FIGURE NO. 1 
Observation reveals that, regarding the chief 
complaints 100% patients were having Shirah-Shoola 
(headache), followed by Hrillas (nausea) and Bhrama 
(vertigo) 88% and 63.33% respectively, Chhardi 
(vomiting) 48%, and Aura 96.66%, which are identical 
to the textual Lakshana (symptoms) of Ardhavabhedaka 
and migraine.   
Regarding the associated symptoms 77.33% 
patients were having Photophobia, 73.33% were having 
Supraorbital pain, 67.33% were having Ocular pain, 
45.33% patients had blurring of vision, 27.33% had 
Lacrimation, 88.66% patients had sleep disturbance, 
77.33% patients had Sleep disturbance, 37.33 patients 
had Stiffness of neck followed by other symptoms, 
which tally with textual Lakshana of Ardhavabhedaka 
and migraine.  
Regarding the Shirah-Shoola, Maximum (72%) 
patients were having unilateral headache, that also 
particularly more in parietal and frontal region i.e., 
88.00% and 74.00% respectively, nature of pain was 
Tivra (sharp) in 66.67% patients. Regarding the quality 
of headache, maximum patients (95.33%) were having 
Shirogaurava followed by others. The intensity of 
headache was Severe in 90.66% of patients. Maximum 
patients (36.66%) were having chronicity of >5 years. 
Maximum patients (88.66%) were having gradual onset 
of headache. The duration 3-6 hours per day of 
headache was seen maximum i.e., 62.66%. Regarding 
frequency, the episode at an interval of ≤ 5 days was 
seen maximum i.e., 51.33%. Maximum patients 
(84.66%) were found to be having continuous nature of 
headache. This shows that majority of the patients either 
have never consulted a doctor or have stopped doing so, 
which suggests the chronicity of disease. It was 
observed that patients rely on painkiller without any 
medical advice given by physician, in a hope to get rid 
of the headache quickly. But it was not going to stop the 
pathology. And the patients, who were taking anti-
migraine drugs, were not responding. This results in 
chronic migraines i.e., rebound or transformed migraine 
headache.  
The maximum Nidanas (etiological factors) 
observed in patients were Amla Aahara (85.33), Lavana 
Aahara (77.33%), Samshana (30.00%), Adhyashna 
(24.66), Vishamashana (17.33%), followed by 
Ratrijagarana 53.33% and Diwaswapa 71.00%. This 
shows faulty lifestyle, which is accepted by today’s 
generation. Intake of junk food, taking food at any time, 
fasting habits of females, etc lead to Agnimandhya and 
Tridosha Dushti, which contributes chiefly in the 
pathogenesis of the disease. Also tyramine and other 
amines present in today’s junk and sour-spicy food 
causes dilation of the nerves in the brain, resulting in a 
rush of blood. Similarly Ratrijagarana (53.33) and 
Diwaswapa (71.33) aggravate Vata and Kapha Dosha 
respectively. Also disturbed sleep was observed in 
maximum patients i.e., 90.00%. Disturbances such as 
sleep deprivation, too much sleep, poor quality of sleep 
and frequent awakening at night are associated with 
both migraine and tension headaches, whereas 
improved sleep habits helps in reducing the frequency 
of migraine headaches. Sleep also has been reported to 
shorten the duration of migraine headaches.  
Environmental factors, like Dhupa (58.00%), 
Dhuli (36.66%), Dhuma (26.00%) causes the Atiyoga 
of Indriyas and serves as a triggering factor. Female’s 
emotional nature, the responsibilities of the family were 
the cause of mental factors such as Chinta (88.66%), 
Krodha (64.00%) and Shoka (06.00%).  
Wrong food and Sunlight were observed as 
maximum triggering factor i.e., 95.33% and 88.66% 
respectively. Bright lights and other high intensity 
visual stimuli can cause headaches in healthy subjects 
as well as patients with migraine headaches, but 
migraine patients seem to have a lower than normal 
threshold for light-induced pain. Sunlight, television 
and flashing lights all have been reported to precipitate 
migraine headaches.  
Noise & air pollution was observed in 82.00%. 
Emotional (68.66%) and physical stress (74.66%) also 
acts as triggering factor. This may lead to Dhatukshaya 
and vitiation of Vata Dosha. Journey (74.66%) served 
as triggering factor because it also leads to vitiation of 
Vata Dosha. Fasting habits (60.66%) served as 
triggering factor because it possibly may precipitate 
migraine headaches by causing the release of stress-
related hormones and lowering blood sugar. 
 
Effect of therapies on signs & symptoms 
Regarding effect of therapy on Chief 
complaints, group A showed significant results. 
Statistically highly significant (<0.001) improvement in 
severity (84.61%), duration (76.92%) and frequency 
(86.20%) of headache was obtained. Regarding effect 
of therapy on Chief complaints in group B statistically 
significant (<0.01) improvement in severity (77%) and 
highly significant (<0.001) improvement in frequency 
(75%) of headache. There was statistically insignificant 
improvement in severity (13%), duration (14%) and 
frequency (18%) of headache in group C. There was 
statistically significant (P<0.01) improvement in 
severity (75%) and frequency (70%) of headache in 
group D.  TABLE NO. 1, 2, 3, 4. 
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Effect of therapy on other chief complaints 
showed that in group A reduction of Nausea (Hrillas) 
87.50% is statistically highly significant 
(P<0.001).Reduction of Vomiting (Chhardi) 89.28% is 
statistically highly significant (P<0.001).Reduction of 
Vertigo (Bharma) 84.37% is statistically highly 
significant (p<0.001). Reduction of Aura 81.81% is 
statistically significant (p<0.01). Reduction of Nausea 
(Hrillas) 66.66% is statistically significant 
(P<0.01).Reduction of Vomiting (Chhardi) 76% is 
statistically highly significant (P<0.001).Reduction of 
Vertigo (Bharma) 66% is statistically significant 
(p<0.01) in group B. All the complaints are statistically 
insignificant at the level of P>0.10 and P>0.05 in group 
C. There was statistically significant (P<0.01) 
improvement in severity (75%) and frequency (70%) of 
headache in group D. TABLE NO. 5, 6, 7, 8. 
 
Total effect of therapy:  
 The overall effect of therapy showed that in 
Group A 38% patients cured and 36% patients got 
marked improvement. In Group B 46.67% patients 
moderately improved and 35.55% patients marked 
improved. In Group C 90% patients unchanged. In 
Group D 48.89% patients moderately improved and 
28.89% patients marked improved. FIGURE NO. 2 
The pharmacodynamics of the drug depends on 
its physiochemical properties, which include Rasa, 
Guna, Virya, Vipaka, Prabhava, etc. The mode of 
action of the therapy can be inferred through the relief 
best owed by the therapy on the exhibited 
symptomatology. 
Chikitsa is the elimination of Samprapti-
Pathogenesis(6). Thus the therapy selected should 
provide positive effect on that particular disease, 
presumably by acting through the alleviation of 
Samprapti which is the resultant of various deranged 
humours and their interactions. 
 
Probable mode of action of Laghu Sutashekhara 
Rasa: 
Action at Doshic level: 
The Snigdha Guna (28.57%), Madhura Vipaka 
(66.67%), Madhura Rasa (20%) and Ushna Virya 
(66.67%) present in Laghu Sutashekhara Rasa tablet 
pacify the Vata Dosha. 
Ruksha Guna (14.29%), Kashaya Rasa (20%), 
Madhura Rasa (20%) and Tikta Rasa (20%), Madhura 
Vipaka (66.67%) and Sheeta Virya (33.33%) pacify the 
Pitta Dosha.  
Laghu Guna (14.29%), Tikshna Guna (14.29%), 
Ruksha Guna (14.29%), Katu Rasa (40%), Tikta Rasa 
(20%), Kashaya Rasa (20%), Katu Vipaka (33.33%) 
and Ushna Virya (66.67%) pacify the Kapha Dosha.  
 
Action at Panchabhautika level: 
Vayu (40%) and Agni (20%) Mahabhoota are 
present maximum in Laghu Sutashekhara Rasa 
compound drug. Vayu due to its Chalatva works as a 
media in Urdhavaga Pravriti and its Laghutava 
enhances the function of Agni Mahabhoota. Thus 
Deepana – Pachana Karma is also seen at Bhautika 
level.  
Prithvi (20%), Jala (10%) and Akasha (10%) 
provide nourishment at Bhautika level due to their 
Balya, Snehana and Mardavakara Karma respectively.  
The compound drug is thus having Shothahara, 
Vedanasthapana, Deepana, Pachana, Sheeta 
prashamana and Tridosha Shamaka Karma.  
 
Probable mode of action of Brihat Dashmoola Taila 
Nasya: 
Action at Doshic level: 
The Snigdha Guna (11.29%), Guru Guna 
(9.68%), Madhura Vipaka (33.33%), Madhura Rasa 
(18.37%), Lavana Rasa (4.08%) and Ushna Virya 
(85.18%) present in Brihat Dashamoola Taila pacify the 
Vata Dosha. 
Ruksha Guna (27.42%), Kashaya Rasa 
(14.29%), Madhura Rasa (18.37%) and Tikta Rasa 
(28.57%), Madhura Vipaka (33.33%) and Sheeta Virya 
(3.70%) pacify the Pitta Dosha.  
Laghu Guna (35.48%), Tikshna Guna (12.90%), 
Ruksha Guna (27.42%), Katu Rasa (34.69%), Tikta 
Rasa (28.57%), Kashaya Rasa (14.29%), Katu Vipaka 
(66.67%) and Ushna Virya (85.18%) pacify the Kapha 
Dosha.  
 
Action at Panchabhautika level: 
Vayu (38.78%) and Agni (19.39%) Mahabhoota 
are present maximum in Brihat Dasahmoola Taila. Vayu 
due to its Chalatva works as a media in Urdhavaga 
Pravriti and its Laghutava enhances the function of 
Agni Mahabhoota. Thus Deepana – Pachana Karma is 
also seen at Bhautika level.  
Jala (9.18%) Mahabhoota has Kledana and 
Bandhana Karma, which acts as a binding agent and 
Akasha (14.29%) Mahabhoota provides proper space 
for the process.  
Prithvi (18.37%) Mahabhoota is having 
Sanghataka and Adhogamana Karma. Hence it takes 
back the already expelled morbid Doshas with an aim to 
remove them from the micro-channels. 
Most of the contents in Brihat Dashmoola Taila are 
having Shothahara, Vedanasthapana, Deepana, 
Pachana and Tridosha Shamaka Karma.  
 
Probable mode of action of Go-Ghrita Nasya: 
Ghrita is supreme in Jangama Sneha and is 
Balavardhaka, Ojovardhaka, Vayasthapana, Agni 
Deepana and Dhatuposhaka. By virtue of its 
Sanskaranuvartana property, it attains the properties of 
ingredients without losing its own. According to 
Acharya Charaka, Ghrita is effective in subsiding 
Pittaja and Vataja disorders; it improves Dhatus and is 
overall booster for improving Ojas(7). Ghrita having 
Balya, Brimhana, Rasayana and Medhya effect which 
can be explained by two ways. Digestion, absorption 
and delivery to the target organ are made easy when any 
drug is processed with Ghrita due to its lipophilic 
action. Anti-oxidant effect of Go-Ghrita is due to its 
Vitamin A and Vitamin E content(8). 
 
Conclusion:  
 Patients from 31-40 yrs of age group, females, 
housewives, married and middle class people were more 
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prone to Migraine. Migraine sufferers had gradual onset 
with severe intensity and unilateral episodic pain with 
continuous rhythm. Triggering factors described in 
modern texts are the Nidanas mentioned by our ancient 
Acharyas. Laghu Sutashekhara Rasa is more effective 
than Brihat Dashamoola Taila Nasya and Go Ghrita 
Nasya. Laghu Sutashekhara Rasa is having significant 
improvement on all the parameters like Shirahshoola, 
Hrillas, Chhardi and on other associated symptoms of 
the disease Ardhavabhedaka.  
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FIGURE NO. 1: GENERAL OBSERVATIONS (n=150):  
 
 
FIGURE NO. 2: OVERALL EFFECT OF THERAPY:                 
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TABLE – 01: EFFECT ON HEADACHE (CHIEF COMPLAINT) IN 50 PATIENTS OF 
ARDHAVABHEDAKA IN GROUP A. 
 
 
TABLE – 02: EFFECT ON HEADACHE (CHIEF COMPLAINT) IN 45 PATIENTS OF 
ARDHAVABHEDAKA IN GROUP B.  
 
 
Table – 03: EFFECT ON HEADACHE (CHIEF COMPLAINT) IN 10 PATIENTS OF 
ARDHAVABHEDAKA IN GROUP C. 
 
 
TABLE – 04: EFFECT ON HEADACHE IN 45 PATIENTS OF ARDHAVABHEDAKA IN GROUP D 
 
 
TABLE – 05: EFFECT ON OTHER CHIEF COMPLAINTS IN 50 PATIENTS IN GROUP A. 
 
Headache 
Mean 
%  of relief 
S.D. 
± 
S.E. 
± 
T P 
B.T. A.T. 
Severity 02.60 0.4 84.61 0.141 0.044 4.90 <0.001 
Duration 01.30 0.3 76.92 0.091 0.028 3.46 <0.01 
Frequency 02.90 0.4 86.20 0.117 0.037 6.70 <0.001 
Headache 
Mean %  of 
relief 
S.D. S.E. T P 
B.T. A.T. 
Severity 2.2 0.5 77.27 0.153 0.048 3.51 <0.01 
Duration 1.0 0.5 50.00 0.052 0.016 3.00 <0.05 
Frequency 2.8 0.6 78.87 0.141 0.044 4.90 <0.001 
Headache 
Mean Score 
% S.D. ± S.E. ± ‘t’ P 
B.T. A.T. 
Severity 2.2 1.9 13.63 0.048 0.015 1.96 >0.05 
Duration 2.1 1.8 14.28 0.042 0.013 1.55 >0.10 
Frequency 2.2 1.8 18.18 0.069 0.022 1.80 >0.10 
Headache 
Mean Score 
% S.D. ± S.E. ± ‘t’ P 
B.T. A.T. 
Severity 1.6 0.4 75.00 0.091 0.029 4.12 <0.01 
Duration 1.2 0.7 41.66 0.052 0.016 3.00 <0.05 
Frequency 2.0 0.6 70.00 0.102 0.032 4.33 <0.01 
Symptoms 
Mean %  of 
relief 
S.D. 
± 
S.E. 
± 
T P 
B.T. A.T. 
Hrillas (Nausea) 2.4 0.3 87.50 0.087 0.027 7.58 <0.001 
Chhardi (Vomiting) 2.8 0.3 89.28 0.117 0.037 6.70 <0.001 
Bhrama (Vertigo) 3.2 0.5 84.37 0.170 0.053 5.01 <0.001 
Purvabhasa (Aura) 2.2 0.4 81.81 0.125 0.039 4.54 <0.01 
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TABLE – 06: EFFECT ON OTHER CHIEF COMPLAINTS IN 15 PATIENTS OF ARDHAVABHEDAKA 
IN GROUP B. 
 
 
Table – 07: EFFECT ON CHIEF COMPLAINTS IN 10 PATIENTS OF ARDHAVABHEDAKA IN GROUP C.
 
 
 
Table – 08: EFFECT OF GROUP D DRUG ON CHIEF COMPLAINTS IN 45 PATIENTS OF 
ARDHAVABHEDAKA 
 
 
 
***** 
Symptoms 
Mean %  of 
relief 
S.D. S.E. T P 
B.T. A.T. 
Hrillas (Nausea) 2.4 0.8 66.66 0.119 0.037 4.22 <0.01 
Chhardi (Vomiting) 2.5 0.6 76.00 0.104 0.033 5.72 <0.001 
Bhrama (Vertigo) 1.9 0.6 68.00 0.127 0.040 3.22 <0.01 
Purvabhasa (Aura) 0.5 0.2 60.00 0.048 0.015 1.96 >0.05 
Chief Complaints 
Mean Score 
% S.D. ± S.E. ± ‘t’ P 
B.T. A.T. 
Hrillas (Nausea) 1.8 1.6 11.11 0.042 0.013 1.50 >0.10 
Chhardi (Vomiting) 1.2 1.0 16.66 0.025 0.008 2.44 >0.05 
Bhrama (Vertigo) 1.6 1.4 12.50 0.034 0.011 1.80 >0.10 
Purvabhasa (Aura) 1.4 1.1 21.42 0.042 0.013 2.25 >0.05 
Chief Complaints 
Mean Score 
% S.D. ± S.E. ± ‘t’ P 
B.T. A.T. 
Hrillas (Nausea) 2.1 0.8 66.66 0.124 0.039 3.56 <0.01 
Chhardi (Vomiting) 2.0 0.6 70.00 0.102 0.032 4.33 <0.01 
Bhrama (Vertigo) 1.2 0.5 58.00 0.094 0.030 2.33 <0.05 
Purvabhasa (Aura) 0.5 0.3 40.00 0.042 0.013 1.50 >0.10 
